Control of herpes simplex virus infections of the genital tract by vaccination.
The apparent increasing incidence of herpes simplex virus infections of the genital tract has focused attention on the efficacy of vaccination in preventing infection or modifying established disease. Results of an 'open trial' using a DNA-free inactivated virus subunit vaccine have shown that vaccination of subjects at risk of contracting infection from their sexual partner reduced the transmission rate from 34% in unvaccinated controls to 0.5%. In a separate study, vaccination of patients who had experienced their first overt attack of herpes genitalis (the initial clinical episode) had significantly fewer recurrences over the follow-up period of 12 months than the unvaccinated control group. The results, we feel, justify a placebo controlled trial.
D000293:Adolescent; D000328:Adult; D000818:Animals; D005260:Female; D006558:Herpes Genitalis / Q000276:immunology / Q000517:prevention & control* / Q000628:therapy; D006801:Humans; D008297:Male; D012008:Recurrence; D014765:Viral Vaccines / Q000008:administration & dosage / Q000627:therapeutic use*
D014765:Viral Vaccines